Skip to main content

Manufacturing


The company has two dedicated state-of-the-art production facilities located in Athens Greece, designed in accordance with EU cGMP requirements:

Oncology Oral Solid Dosage Forms (inaugurated in 2007)

  • Product Forms: tablets (uncoated or coated) & hard gelatin capsules
  • Molecules handled: Anastrozole, Bicalutamide, Exemestane, Finasteride, Flutamide, Hydroxyurea, Letrozole, Tamoxifen, Thioguanine & Gefitinib
  • Granulation Capacity: up to 150kg
  • Primary Packaging: blisters
  • Full Capacity: 140 million tablets, 10 million capsules
  • Accreditations: EU GMP, Gulf Countries Council (GCC), Health Canada, Therapeutic Goods Administration (TGA-Australia)
  • Anvisa accreditation
  • Russian authorities accreditation

Conventional Solid Dosage Forms (renovated in 2005)

  • Product Forms: tablets (uncoated, coated, orodispersible and chewable), hard gelatin capsules.
  • Molecules handled: more than thirty-five (35).
  • Primary Packaging: blisters.
  • Full Capacity: 500 million tablets, 40 million capsules.
  • Accreditations: EU GMP, Gulf Countries Council (GCC), Health Canada, Therapeutic Goods Administration (TGA-Australia)
  • Anvisa accreditation
  • Russian authorities accreditation

Accreditations

  • ISO 9001:2015
  • EU GMP
  • GCC GMP
  • Health Canada
  • Taiwan GMP
  • Korea Ministry of Health
  • Kazakhstan GMP
  • Pakistan GMP
  • Sudan GMP
  • Joranian GMP
  • Philippines GMP
  • Iran GMP
  • Anvisa GMP
  • Russia GMP
Genepharm

Please read our Cookies Policy for more information.
✅ Strictly necessary cookies allow basic website functions, such as website navigation

Design Escapes

GENEPHARM S.A.
18km Marathon Avenue 15351 Pallini, Greece
Tel: +30 210 603 9336
Fax: +30 210 603 9402
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
GEMI REGISTRATION NUMBER 000276001000


© WebSite and Digital Marketing by EarthOnWire.